Dr Catherine Houlihan

Consultant in Infection, UK Health Security Agency (UKHSA), and Consultant in Clinical Virology, UCLH

Catherine Houlihan is an MRCP and FRCPath qualified infectious disease and virology consultant, jointly appointed as a substantive consultant 50% in clinical virology at UCLH and 50% as a consultant in infection at the Rare and Imported Pathogens Laboratory, UK Health Security Agency. 

Catherine’s PhD is from LSHTM in Epidemiology and her current research interests are in emerging viral infections, CNS infections, and nosocomial infection including in health care workers.  She teaches tropical medicine and epidemiology at LSHTM and is an honorary assistant professor at UCL.  

Catherine is the UCLH site PI of a clinical trial of influenza antivirals (REMAP-CAP) and was previously site PI for trials of monoclonal antibodies for the prevention of SARS-CoV-2 in exposed individuals. She is the PI or co-PI of four ongoing epidemiological studies.  

Catherine has worked on VHF outbreak response for the WHO in Sierra Leone, Nigeria and DRC and she is a member of UK-Med, a frontline medical aid charity.